Tiffany M Powell-Wiley1, Julius Ngwa2, Selomie Kebede2, Di Lu3, Phillip J Schulte4, Deepak L Bhatt5, Clyde Yancy6, Gregg C Fonarow7, Michelle A Albert8. 1. Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: tiffany.powell-wiley@nih.gov. 2. Division of Cardiovascular Medicine, Howard University Hospital and School of Medicine, Washington, DC. 3. Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina. 4. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. 5. Heart and Vascular Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 6. Cardiovascular Division, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 7. Ronald Reagan University of California at Los Angeles Medical Center, Los Angeles, California. 8. Center for the Study of Adversity and Cardiovascular Disease (NURTURE Center), Cardiology Division, University of California at San Francisco Medical Center, San Francisco, California.
Abstract
OBJECTIVES: This study sought to evaluate the influence of race/ethnicity on the relationship between body mass index (BMI) and mortality in heart failure with preserved ejection fraction (HFpEF) and HF with reduced EF (HFrEF) patients. BACKGROUND: Prior studies demonstrated an "obesity paradox" among overweight and obese patients, where they have a better HF prognosis than normal weight patients. Less is known about the relationship between BMI and mortality among diverse patients with HF, particularly given disparities in obesity and HF prevalence. METHODS: The authors used Get With The Guidelines-Heart Failure data to assess the relationship between BMI and in-hospital mortality by using logistic regression modeling. The authors assessed 30-day and 1-year rates of all-cause mortality following discharge by using Cox regression modeling. RESULTS: A total of 39,647 patients with HF were included (32,434 [81.8%] white subjects; 3,809 [9.6%] black subjects; 1,928 [4.9%] Hispanic subjects; 544 [1.4%] Asian subjects; and 932 [2.3%] other subjects); 59.7% of subjects had HFpEF, and 30.7% were obese. More black and Hispanic patients had Class I or higher obesity (BMI ≥30 kg/m2) than whites, Asians, or other racial/ethnic groups (p < 0.0001). Among subjects with HFpEF, higher BMI was associated with lower 30-day mortality, up to 30 kg/m2 with a small risk increase above 30 kg/m2 (BMI: 30 vs. 18.5 kg/m2), hazard ratio (HR) of 0.63 (95% confidence interval [CI]: 0.54 to 0.73). A modest relationship was observed in HFrEF subjects (BMI: 30 vs. 18.5 kg/m2; HR: 0.73; 95% CI: 0.60 to 0.89), with no risk increase above 30 kg/m2. There were no significant interactions between BMI and race or ethnicity related to 30-day mortality (p > 0.05). CONCLUSIONS: This work is one of the first suggesting the obesity paradox for 30-day mortality exists at all BMI levels in HFrEF but not in patients with HFpEF. Higher BMI was associated with lower 30-day mortality across racial/ethnic groups in a manner inconsistent with the J-shaped relationship noted for coronary artery disease. The differential slope of obesity and mortality among HFpEF and patients with HFrEF potentially suggests differing mechanistic factors, requiring further exploration. Published by Elsevier Inc.
OBJECTIVES: This study sought to evaluate the influence of race/ethnicity on the relationship between body mass index (BMI) and mortality in heart failure with preserved ejection fraction (HFpEF) and HF with reduced EF (HFrEF) patients. BACKGROUND: Prior studies demonstrated an "obesity paradox" among overweight and obesepatients, where they have a better HF prognosis than normal weight patients. Less is known about the relationship between BMI and mortality among diverse patients with HF, particularly given disparities in obesity and HF prevalence. METHODS: The authors used Get With The Guidelines-Heart Failure data to assess the relationship between BMI and in-hospital mortality by using logistic regression modeling. The authors assessed 30-day and 1-year rates of all-cause mortality following discharge by using Cox regression modeling. RESULTS: A total of 39,647 patients with HF were included (32,434 [81.8%] white subjects; 3,809 [9.6%] black subjects; 1,928 [4.9%] Hispanic subjects; 544 [1.4%] Asian subjects; and 932 [2.3%] other subjects); 59.7% of subjects had HFpEF, and 30.7% were obese. More black and Hispanic patients had Class I or higher obesity (BMI ≥30 kg/m2) than whites, Asians, or other racial/ethnic groups (p < 0.0001). Among subjects with HFpEF, higher BMI was associated with lower 30-day mortality, up to 30 kg/m2 with a small risk increase above 30 kg/m2 (BMI: 30 vs. 18.5 kg/m2), hazard ratio (HR) of 0.63 (95% confidence interval [CI]: 0.54 to 0.73). A modest relationship was observed in HFrEF subjects (BMI: 30 vs. 18.5 kg/m2; HR: 0.73; 95% CI: 0.60 to 0.89), with no risk increase above 30 kg/m2. There were no significant interactions between BMI and race or ethnicity related to 30-day mortality (p > 0.05). CONCLUSIONS: This work is one of the first suggesting the obesity paradox for 30-day mortality exists at all BMI levels in HFrEF but not in patients with HFpEF. Higher BMI was associated with lower 30-day mortality across racial/ethnic groups in a manner inconsistent with the J-shaped relationship noted for coronary artery disease. The differential slope of obesity and mortality among HFpEF and patients with HFrEF potentially suggests differing mechanistic factors, requiring further exploration. Published by Elsevier Inc.
Authors: R Padwal; F A McAlister; J J V McMurray; M R Cowie; M Rich; S Pocock; K Swedberg; A Maggioni; G Gamble; C Ariti; N Earle; G Whalley; K K Poppe; R N Doughty; A Bayes-Genis Journal: Int J Obes (Lond) Date: 2013-10-31 Impact factor: 5.095
Authors: Gregg C Fonarow; Preethi Srikanthan; Maria Rosa Costanzo; Guillermo B Cintron; Margarita Lopatin Journal: Am Heart J Date: 2007-01 Impact factor: 4.749
Authors: Sandeep R Das; Karen P Alexander; Anita Y Chen; Tiffany M Powell-Wiley; Deborah B Diercks; Eric D Peterson; Matthew T Roe; James A de Lemos Journal: J Am Coll Cardiol Date: 2011-12-13 Impact factor: 24.094
Authors: Rey P Vivo; Selim R Krim; Nassim R Krim; Xin Zhao; Adrian F Hernandez; Eric D Peterson; Ileana L Piña; Deepak L Bhatt; Lee H Schwamm; Gregg C Fonarow Journal: Circ Heart Fail Date: 2012-03-13 Impact factor: 8.790
Authors: Carl J Lavie; Martin A Alpert; Ross Arena; Mandeep R Mehra; Richard V Milani; Hector O Ventura Journal: JACC Heart Fail Date: 2013-04-01 Impact factor: 12.035
Authors: Khadijah Breathett; Iris Leng; Randi E Foraker; William T Abraham; Laura Coker; Keith E Whitfield; Sally Shumaker; JoAnn E Manson; Charles B Eaton; Barbara V Howard; Nkechinyere Ijioma; Crystal W Cené; Lisa W Martin; Karen C Johnson; Liviu Klein Journal: Circ Heart Fail Date: 2018-05 Impact factor: 8.790
Authors: Carlo Fumagalli; Niccolò Maurizi; Sharlene M Day; Euan A Ashley; Michelle Michels; Steven D Colan; Daniel Jacoby; Niccolò Marchionni; Justin Vincent-Tompkins; Carolyn Y Ho; Iacopo Olivotto Journal: JAMA Cardiol Date: 2020-01-01 Impact factor: 14.676
Authors: Melissa C Caughey; Muthiah Vaduganathan; Sameer Arora; Arman Qamar; Robert J Mentz; Patricia P Chang; Clyde W Yancy; Stuart D Russell; Sanjiv J Shah; Wayne D Rosamond; Ambarish Pandey Journal: J Am Geriatr Soc Date: 2021-01-05 Impact factor: 5.562
Authors: Janice Y Chyou; Wan Ting Tay; Inder S Anand; Tiew-Hwa Katherine Teng; Jonathan J L Yap; Michael R MacDonald; Vijay Chopra; Seet Yoong Loh; Wataru Shimizu; Imran Zainal Abidin; Arthur Mark Richards; Javed Butler; Carolyn S P Lam Journal: J Am Heart Assoc Date: 2021-03-13 Impact factor: 5.501